Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.30 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737845 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL61818 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL542776 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL13858690 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL9956415 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL25327994 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL7340365 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL11594630 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL625943 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL61394 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117222637-A | EGFR degrading agents and related methods of use | 百济神州有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-113999158-B | 3- (1-hydroxyalkylene) indolone and preparation method thereof | 延边大学 | 2023-08-01 | — | — | CN | claimed |
| EP-2513086-A1 | NOVEL ANTAGONISTS FOR CCR2 AND USES THEREOF | Boehringer Ingelheim International GmbH (DE) | 2012-10-24 | — | — | EP | claimed |
| EP-2513093-A1 | NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF | Boehringer Ingelheim International GmbH (DE) | 2012-10-24 | — | — | EP | claimed |
| US-20110212960-A1 | NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDER | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-09-01 | — | — | US | claimed |
| WO-2011073154-A1 | NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-06-23 | — | — | WO | claimed |
| WO-2011073155-A1 | NOVEL ANTAGONISTS FOR CCR2 AND USES THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-06-23 | — | — | WO | claimed |
| WO-2011018495-A1 | NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-17 | — | — | WO | claimed |
| EP-1237850-B1 | GLYOXYL ACID AMIDES | BAYER CROPSCIENCE AG (DE) | 2005-02-09 | — | — | EP | claimed |
| EP-1237850-A2 | GLYOXYL ACID AMIDES | Bayer Aktiengesellschaft (DE) | 2002-09-11 | — | — | EP | claimed |
| US-6313173-B1 | USED AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | claimed |
| WO-2001039787-A2 | GLYOXYL ACID AMIDES, METHOD FOR PRODUCING THEM AND THEIR USE FOR CONTROLLING HARMFUL ORGANISMS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-07 | — | — | WO | claimed |
| EP-0989971-A1 | GLYOXYLIC ACID AMIDES | Bayer Aktiengesellschaft (DE) | 2000-04-05 | — | — | EP | claimed |
| EP-0946504-A1 | COMPOUNDS USEFUL FOR PERHALOGENOALKYLATION, REAGENT FOR IMPLEMENTING THESE COMPOUNDS AND SYNTHESIS METHOD FOR OBTAINING THESE COMPOUNDS | RHODIA CHIMIE (FR) | 1999-10-06 | — | — | EP | claimed |
| EP-0941215-A1 | GLYOXYLIC ACID AMIDES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 1999-09-15 | — | — | EP | claimed |
| WO-1998058903-A1 | GLYOXYLIC ACID AMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-12-30 | — | — | WO | claimed |
| WO-1998022434-A1 | GLYOXYLIC ACID AMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-05-28 | — | — | WO | claimed |
| WO-1998022435-A1 | COMPOUNDS USEFUL FOR PERHALOGENOALKYLATION, REAGENT FOR IMPLEMENTING THESE COMPOUNDS AND SYNTHESIS METHOD FOR OBTAINING THESE COMPOUNDS | RHODIA CHIMIE (FR) | 1998-05-28 | — | — | WO | claimed |
| US-11999754-B2 | Ruthenium complexes and their use in olefin metathesis reactions | APEIRON SYNTHESIS S.A. (PL) | 2024-06-04 | — | — | US | disclosed |
| US-3962201-A | PROCESS FOR POLYMERIZING ACRYLICS EMPLOYING (HYDROCARBON-PEROXY HYDROCARBON) PHOSPHONATES | S. A. TEXACO BELGIUM N.V. (BE) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11999754-B2 | Ruthenium complexes and their use in olefin metathesis reactions | ADH1A, CYP2E1, OPRM1 | KMT2A 4018/4885NISCH 1086/4885CA1 1350/4885 |
| US-20110212960-A1 | NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDER | BDNF, PSEN1, CHRNA5 | KMT2A 1624/4885NISCH 99/4885CA1 565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.